CCL2 and tuberculosis: We found that there was an improvement in liver pathology when Glis2 was imported externally, reflected in a reduction in liver injury biomarkers (ALT, AST, and TB), inflammatory biomarkers (IL-1β, IL-8, TNF-α, and CCL-2), and fibrosis biomarkers (desmin and α-SMA) (Fig. 3c–g).